Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases

Código QR

Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases

Guardado en:

Detalles Bibliográficos
Autores principales:	Cong-Qiu Chu, Li-Shao Guo
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/f4aee52fe56c4894b53790658d72b4c3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy
por: Limeng Cai, et al.
Publicado: (2021)

Paving the way toward better peer review
Publicado: (2016)

US Tobacco 21 is Paving the Way for a Tobacco Endgame
por: Samuel C J Kim, et al.
Publicado: (2021)

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease
por: Al-Meghaiseeb ES, et al.
Publicado: (2016)

Bacterial Swarms Recruit Cargo Bacteria To Pave the Way in Toxic Environments
por: Alin Finkelshtein, et al.
Publicado: (2015)

A new human genome sequence paves the way for individualized genomics.
por: Liza Gross
Publicado: (2007)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais E, et al.
Publicado: (2020)

Biosensors paving the way to understanding the interaction between cadmium and the estrogen receptor alpha.
por: Peter Fechner, et al.
Publicado: (2011)

REVIEW: How soldier guitars, culture and faith paved way for Bougainville’s peace
por: David Robie
Publicado: (2019)

Integrated multilayer stretchable printed circuit boards paving the way for deformable active matrix
por: Shantonu Biswas, et al.
Publicado: (2019)

Recycled Precast Concrete Kerbs and Paving Blocks, a Technically Viable Option for Footways
por: Andrés Juan-Valdés, et al.
Publicado: (2021)

No yield penalty under favorable conditions paving the way for successful adoption of flood tolerant rice
por: Manzoor H. Dar, et al.
Publicado: (2018)

Paving the Way for Circular Supply Chains: Conceptualization of a Circular Supply Chain Maturity Framework
por: Laura Montag, et al.
Publicado: (2021)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Eugeniusz Józef Kucharz, et al.
Publicado: (2021)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Roman Fischer, et al.
Publicado: (2017)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Ganglei Li, et al.
Publicado: (2021)

Functional adaptation of a plant receptor-kinase paved the way for the evolution of intracellular root symbioses with bacteria.
por: Katharina Markmann, et al.
Publicado: (2008)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Violet R. Mukaro, et al.
Publicado: (2018)

Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer&rsquo;s disease
por: Fiona E McAlpine, et al.
Publicado: (2008)

There exists only one tumor necrosis factor
por: S. A. Nedospasov
Publicado: (2021)

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease
por: Chih-Jan Ko, et al.
Publicado: (2021)

A Novel Approach to the Holistic 3D Characterization of Weld Seams—Paving the Way for Deep Learning-Based Process Monitoring
por: Maximilian Schmoeller, et al.
Publicado: (2021)

The road to hell is paved with good intentionality
por: Carin-Isabel Knoop
Publicado: (2021)

Paving the path to the future of carbogenic nanodots
por: Navneet C. Verma, et al.
Publicado: (2019)

Study on Noise Reduction with Paving Different Low Noise Pavement Materials
por: Minmin Yuan, et al.
Publicado: (2021)

Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor
por: Timothy G. Brandon, et al.
Publicado: (2021)

Roles Of Tumor Necrosis Factor In Animal Tissues : Review Article
por: H.B.Al-sabaawy, et al.
Publicado: (2020)

LEVELS OF TUMOR NECROSIS FACTOR ALPHA IN PATIENTS WITH ISCHEMIC STROKE
por: I. A. Prilutskaya, et al.
Publicado: (2019)

Tumor necrosis factor prevents Candida albicans biofilm formation
por: Francisco Airton Castro Rocha, et al.
Publicado: (2017)

BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity
por: Anne Margriet Heijink, et al.
Publicado: (2019)

The Effect of Phototherapy on Serum Level of Tumor Necrosis Factor Alpha in Neonates
por: Mohamed Neam, et al.
Publicado: (2020)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Sudheer K. Vuyyuru, et al.
Publicado: (2021)

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Nirit Mor-Vaknin, et al.
Publicado: (2017)

Therapeutic Alternatives for the Treatment of Infected Pancreatic Necrosis: An Overview
por: Manterola,Carlos, et al.
Publicado: (2014)

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
por: Yiming Leng, et al.
Publicado: (2021)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini I, et al.
Publicado: (2020)

Lung adenocarcinoma with mixed solid and crazy‐paving appearances
por: Roqiah Fatmawati Abdul Kadir, et al.
Publicado: (2021)

Paving the Road for the Adoption of Normothermic Regional Perfusion in Canada
por: John Basmaji, MD, et al.
Publicado: (2021)

PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: E. N. Zotina, et al.
Publicado: (2016)

Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma
por: Kondkar AA, et al.
Publicado: (2018)